Cargando…

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Altaf, Dashwood, Roderick H., Dickinson, Sally, Disis, Mary L., Jaffee, Elizabeth M., Johnson, Bryon D., Khleif, Samir N., Pollak, Michael N., Schlom, Jeffrey, Shoemaker, Robert H., Stanton, Sasha E., Wondrak, Georg T., You, Ming, Zhu, Hao, Miller, Mark Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749317/
https://www.ncbi.nlm.nih.gov/pubmed/35047458
http://dx.doi.org/10.15430/JCP.2021.26.4.309
_version_ 1784631200390840320
author Mohammed, Altaf
Dashwood, Roderick H.
Dickinson, Sally
Disis, Mary L.
Jaffee, Elizabeth M.
Johnson, Bryon D.
Khleif, Samir N.
Pollak, Michael N.
Schlom, Jeffrey
Shoemaker, Robert H.
Stanton, Sasha E.
Wondrak, Georg T.
You, Ming
Zhu, Hao
Miller, Mark Steven
author_facet Mohammed, Altaf
Dashwood, Roderick H.
Dickinson, Sally
Disis, Mary L.
Jaffee, Elizabeth M.
Johnson, Bryon D.
Khleif, Samir N.
Pollak, Michael N.
Schlom, Jeffrey
Shoemaker, Robert H.
Stanton, Sasha E.
Wondrak, Georg T.
You, Ming
Zhu, Hao
Miller, Mark Steven
author_sort Mohammed, Altaf
collection PubMed
description The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunoprevention. The workshop included an overview of the mechanistic classes of immunomodulatory agents and three sessions covering the gamut from preclinical to clinical studies. The workshop convened individuals working in immunology and cancer prevention to discuss trends in discovery and development of immunomodulatory agents individually and in combination with other chemopreventive agents or vaccines.
format Online
Article
Text
id pubmed-8749317
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society of Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-87493172022-01-18 Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report Mohammed, Altaf Dashwood, Roderick H. Dickinson, Sally Disis, Mary L. Jaffee, Elizabeth M. Johnson, Bryon D. Khleif, Samir N. Pollak, Michael N. Schlom, Jeffrey Shoemaker, Robert H. Stanton, Sasha E. Wondrak, Georg T. You, Ming Zhu, Hao Miller, Mark Steven J Cancer Prev Meeting Report The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunoprevention. The workshop included an overview of the mechanistic classes of immunomodulatory agents and three sessions covering the gamut from preclinical to clinical studies. The workshop convened individuals working in immunology and cancer prevention to discuss trends in discovery and development of immunomodulatory agents individually and in combination with other chemopreventive agents or vaccines. Korean Society of Cancer Prevention 2021-12-30 2021-12-30 /pmc/articles/PMC8749317/ /pubmed/35047458 http://dx.doi.org/10.15430/JCP.2021.26.4.309 Text en Copyright © 2021 Korean Society of Cancer Prevention https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Report
Mohammed, Altaf
Dashwood, Roderick H.
Dickinson, Sally
Disis, Mary L.
Jaffee, Elizabeth M.
Johnson, Bryon D.
Khleif, Samir N.
Pollak, Michael N.
Schlom, Jeffrey
Shoemaker, Robert H.
Stanton, Sasha E.
Wondrak, Georg T.
You, Ming
Zhu, Hao
Miller, Mark Steven
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
title Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
title_full Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
title_fullStr Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
title_full_unstemmed Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
title_short Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
title_sort translational advances in cancer prevention agent development (tacpad) virtual workshop on immunomodulatory agents: report
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749317/
https://www.ncbi.nlm.nih.gov/pubmed/35047458
http://dx.doi.org/10.15430/JCP.2021.26.4.309
work_keys_str_mv AT mohammedaltaf translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT dashwoodroderickh translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT dickinsonsally translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT disismaryl translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT jaffeeelizabethm translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT johnsonbryond translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT khleifsamirn translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT pollakmichaeln translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT schlomjeffrey translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT shoemakerroberth translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT stantonsashae translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT wondrakgeorgt translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT youming translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT zhuhao translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport
AT millermarksteven translationaladvancesincancerpreventionagentdevelopmenttacpadvirtualworkshoponimmunomodulatoryagentsreport